Search research articles
Contact Us
Filters
Showing results (171-180 of 219) with videos related to
Page
of 22
Sort By:
European Journal of Heart Failure
|
February 17, 2015
Suppression of neutrophil superoxide generation by BNP is attenuated in acute heart failure: a case for 'BNP resistance'
Saifei Liu, Doan T M Ngo, Cher-Rin Chong, et al.
British Journal of Pharmacology
|
October 21, 2010
Ramipril retards development of aortic valve stenosis in a rabbit model: mechanistic considerations
Doan Tm Ngo, Irene Stafford, Aaron L Sverdlov, et al.
Journal of the American College of Cardiology
|
September 29, 2012
Impact of home versus clinic-based management of chronic heart failure: the WHICH? (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Friendly in Reducing Hospital Care) multicenter, randomized trial
Simon Stewart, Melinda J Carrington, Thomas H Marwick, et al.
American Journal of Cardiovascular Disease
|
August 27, 2015
Subtle renal dysfunction and bleeding risk in atrial fibrillation: symmetric dimethylarginine predicts HAS-BLED score
Nathan Ek Procter, Jocasta Ball, Tamila Heresztyn, et al.
British Journal of Pharmacology
|
April 2, 2022
Cardioprotective actions of nitroxyl donor Angeli's salt are preserved in the diabetic heart and vasculature in the face of nitric oxide resistance
Anida Velagic, Jasmin Chendi Li, Cheng Xue Qin, et al.
Circulation
|
October 9, 2014
Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
Lars Wallentin, Ziad Hijazi, Ulrika Andersson, et al.
Frontiers in Psychiatry
|
May 2, 2022
Transdiagnostic Cognitive-Behavioral Therapy for Depression and Anxiety Disorders in Cardiovascular Disease Patients: Results From the CHAMPS Pilot-Feasibility Trial
Phillip J Tully, Deborah A Turnbull, John D Horowitz, et al.
Lancet (London, England)
|
December 4, 2014
Standard versus atrial fibrillation-specific management strategy (SAFETY) to reduce recurrent admission and prolong survival: pragmatic, multicentre, randomised controlled trial
Simon Stewart, Jocasta Ball, John D Horowitz, et al.
Pharmacogenetics and Genomics
|
April 13, 2007
Effect of CYP2D6 metabolizer status on the disposition of the (+) and (-) enantiomers of perhexiline in patients with myocardial ischaemia
Sally C Inglis, Megan K Herbert, Benjamin J L Davies, et al.
Heart, Lung & Circulation
|
November 10, 2020
Takotsubo Syndrome: Finally Emerging From the Shadows?
Gao Jing Ong, Thanh Ha Nguyen, Angela Kucia, et al.
Page
of 22
Search research articles
Search
Showing results (171-180 of 219) with videos related to
Sort By:
Page
of 22
European Journal of Heart Failure
|
February 17, 2015
Suppression of neutrophil superoxide generation by BNP is attenuated in acute heart failure: a case for 'BNP resistance'
Saifei Liu, Doan T M Ngo, Cher-Rin Chong, et al.
British Journal of Pharmacology
|
October 21, 2010
Ramipril retards development of aortic valve stenosis in a rabbit model: mechanistic considerations
Doan Tm Ngo, Irene Stafford, Aaron L Sverdlov, et al.
Journal of the American College of Cardiology
|
September 29, 2012
Impact of home versus clinic-based management of chronic heart failure: the WHICH? (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Friendly in Reducing Hospital Care) multicenter, randomized trial
Simon Stewart, Melinda J Carrington, Thomas H Marwick, et al.
American Journal of Cardiovascular Disease
|
August 27, 2015
Subtle renal dysfunction and bleeding risk in atrial fibrillation: symmetric dimethylarginine predicts HAS-BLED score
Nathan Ek Procter, Jocasta Ball, Tamila Heresztyn, et al.
British Journal of Pharmacology
|
April 2, 2022
Cardioprotective actions of nitroxyl donor Angeli's salt are preserved in the diabetic heart and vasculature in the face of nitric oxide resistance
Anida Velagic, Jasmin Chendi Li, Cheng Xue Qin, et al.
Circulation
|
October 9, 2014
Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
Lars Wallentin, Ziad Hijazi, Ulrika Andersson, et al.
Frontiers in Psychiatry
|
May 2, 2022
Transdiagnostic Cognitive-Behavioral Therapy for Depression and Anxiety Disorders in Cardiovascular Disease Patients: Results From the CHAMPS Pilot-Feasibility Trial
Phillip J Tully, Deborah A Turnbull, John D Horowitz, et al.
Lancet (London, England)
|
December 4, 2014
Standard versus atrial fibrillation-specific management strategy (SAFETY) to reduce recurrent admission and prolong survival: pragmatic, multicentre, randomised controlled trial
Simon Stewart, Jocasta Ball, John D Horowitz, et al.
Pharmacogenetics and Genomics
|
April 13, 2007
Effect of CYP2D6 metabolizer status on the disposition of the (+) and (-) enantiomers of perhexiline in patients with myocardial ischaemia
Sally C Inglis, Megan K Herbert, Benjamin J L Davies, et al.
Heart, Lung & Circulation
|
November 10, 2020
Takotsubo Syndrome: Finally Emerging From the Shadows?
Gao Jing Ong, Thanh Ha Nguyen, Angela Kucia, et al.
Page
of 22